Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease
- 21 October 2019
- journal article
- research article
- Published by Elsevier in Neurotherapeutics
- Vol. 17 (1) , 371-387
Abstract
No abstract availableKeywords
Funding Information
- Auckland UniServices (5000293)
- New Zealand Lottery Health Research (3702828)
- Maurice and Phyllis Paykel Trust (3708721)
- New Zealand Optometric Vision Research Foundation (3717092)
This publication has 57 references indexed in Scilit:
- Glucose increases intracellular free Ca2+ in tanycytes via ATP released through connexin 43 hemichannelsGlia, 2011
- Blockade of Gap Junction Hemichannel Suppresses Disease Progression in Mouse Models of Amyotrophic Lateral Sclerosis and Alzheimer's DiseasePLOS ONE, 2011
- Characterization of retinal function and glial cell response in a mouse model of oxygen‐induced retinopathyJournal of Comparative Neurology, 2010
- Efficacy and Safety of Tonabersat, a Gap-Junction Modulator, in the Acute Treatment of Migraine: A Double-Blind, Parallel-group, Randomized StudyCephalalgia, 2009
- Tonabersat, a Gap-Junction Modulator: Efficacy and Safety in Two Randomized, Placebo-Controlled, Dose-Ranging Studies of Acute MigrainecephCephalalgia, 2009
- Tonabersat, A Novel Gap-Junction Modulator for the Prevention of MigraineCephalalgia, 2009
- Rodent electroretinography: Methods for extraction and interpretation of rod and cone responsesProgress in Retinal and Eye Research, 2008
- Connexin43 Mimetic Peptides Reduce Swelling, Astrogliosis, and Neuronal Cell Death after Spinal Cord InjuryCell Communication & Adhesion, 2008
- Characterization of Streptozotocin-induced Diabetic Rats and Pharmacodynamics of Insulin FormulationsBioscience, Biotechnology, and Biochemistry, 2003
- Connexin43 and astrocytic gap junctions in the rat spinal cord after acute compression injuryJournal of Comparative Neurology, 1997